Story

US Court Grants WuXi AppTec Preliminary Injunction Against DoD's 1260H Listing

ENTHMSVIIDZHZH-TWJAKOHI
Aug 9, 20262 min read
US Court Grants WuXi AppTec Preliminary Injunction Against DoD's 1260H Listing
Text size
Background

A U.S. federal court has granted a preliminary injunction to WuXi AppTec (603259.SH), temporarily blocking the Department of Defense (DoD) from taking action based on its designation of the pharmaceutical services giant on the 1260H list.

The ruling provides the company temporary relief from potential adverse effects as it continues its legal challenge against the U.S. government's classification.

Court Approves Injunction

According to a company announcement, the U.S. District Court for the District of Columbia issued the decision on August 7, 2026, following a hearing on July 22. WuXi AppTec had filed the motion for a preliminary injunction on June 29, 2026.

The injunction prohibits the DoD from enforcing, implementing, or otherwise acting on the 1260H designation for the duration of the company's lawsuit. WuXi AppTec said in a statement that it welcomed the ruling, noting that it protects the company from "immediate adverse effects" while the judicial process unfolds.

Background of the Legal Challenge

Sample IUX Markets – In-articleAd

The dispute stems from the DoD's decision to include WuXi AppTec on its list of "Chinese military companies" operating directly or indirectly in the United States, as defined under Section 1260H of the National Defense Authorization Act.

WuXi AppTec filed a lawsuit against the DoD on June 11, 2026, strongly opposing what it termed an "erroneous" designation. The company stated that the legal action was necessary to protect the interests of its shareholders, employees, partners, and clients.

Implications for the Company

While the 1260H list does not impose immediate sanctions, inclusion can carry significant reputational risk and potentially deter U.S. entities from conducting business with listed firms. This preliminary injunction temporarily mitigates that risk for WuXi AppTec.

The company reassured stakeholders that its business operations are proceeding normally. It added that it remains confident that "the facts will ultimately be clarified after an objective and fair judicial review."

Read next

More on Stocks
Back to latest news

LATEST